Cargando…

Editorial: Contribution of Uremic Compounds to Cardiorenal Syndrome Development

Detalles Bibliográficos
Autores principales:	Carneiro-Ramos, Marcela Sorelli, Ruiz-Hurtado, Gema, Vieyra, Adalberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158741/ https://www.ncbi.nlm.nih.gov/pubmed/35665219 http://dx.doi.org/10.3389/fphys.2022.877182

Ejemplares similares

An Overview of the Role of Calcium/Calmodulin-Dependent Protein Kinase in Cardiorenal Syndrome
por: Junho, Carolina Victoria Cruz, et al.
Publicado: (2020)

Uremic Toxins: An Alarming Danger Concerning the Cardiovascular System
por: Falconi, Carlos Alexandre, et al.
Publicado: (2021)

Immune Cells Are Differentially Modulated in the Heart and the Kidney during the Development of Cardiorenal Syndrome 3
por: Vernier, Imara Caridad Stable, et al.
Publicado: (2023)

Fibroblast Growth Factor-23-Klotho Axis in Cardiorenal Syndrome: Mediators and Potential Therapeutic Targets
por: Navarro-García, José Alberto, et al.
Publicado: (2021)

Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome
por: Lekawanvijit, Suree
Publicado: (2018)

Mitochondrial Dysfunction in Cardiorenal Syndrome 3: Renocardiac Effect of Vitamin C
por: Neres-Santos, Raquel Silva, et al.
Publicado: (2021)

The molecular mechanisms and intervention strategies of mitophagy in cardiorenal syndrome
por: Yao, Mengying, et al.
Publicado: (2022)

Characterization of the Oxidative Stress in Renal Ischemia/Reperfusion-Induced Cardiorenal Syndrome Type 3
por: Caio-Silva, Wellington, et al.
Publicado: (2020)

Editorial: Evolving Picture of Calcium Handling in Cardiac Disease
por: Ruiz-Hurtado, Gema, et al.
Publicado: (2020)

The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction
por: da Cunha, Regiane Stafim, et al.
Publicado: (2022)

Editorial: New Advances in Cardiorenal Syndrome
por: Calvier, Laurent, et al.
Publicado: (2022)

Microalbuminuria and cardiorenal risk: old and new evidence in different populations
por: Márquez, Diego Francisco, et al.
Publicado: (2019)

Apoptosis signal-regulating kinase 1 inhibition attenuates cardiac hypertrophy and cardiorenal fibrosis induced by uremic toxins: Implications for cardiorenal syndrome
por: Savira, Feby, et al.
Publicado: (2017)

Unilateral Acute Renal Ischemia-Reperfusion Injury Induces Cardiac Dysfunction through Intracellular Calcium Mishandling
por: Junho, Carolina Victoria Cruz, et al.
Publicado: (2022)

Multimodal Strategies for the Diagnosis and Management of Refractory Congestion. An Integrated Cardiorenal Approach
por: Rodríguez-Espinosa, Diana, et al.
Publicado: (2022)

Cardiorenal ketone metabolism: a positron emission tomography study in healthy humans
por: Cuenoud, Bernard, et al.
Publicado: (2023)

The Cardiorenal Syndrome
por: Rosner, Mitchell H., et al.
Publicado: (2011)

Cardiorenal syndrome
por: Schetz, Miet
Publicado: (2009)

Cardiorenal syndrome
por: Ye, Wen Qing Wendy, et al.
Publicado: (2023)

Targeting immunometabolism during cardiorenal injury: roles of conventional and alternative macrophage metabolic fuels
por: Mouton, Alan J., et al.
Publicado: (2023)

The Uremic Toxin Adsorbent AST-120 Abrogates Cardiorenal Injury Following Myocardial Infarction
por: Lekawanvijit, Suree, et al.
Publicado: (2013)

Mitochondrial Dysfunction in Kidney Disease and Uremic Sarcopenia
por: Takemura, Koji, et al.
Publicado: (2020)

Central role of carotid body chemoreceptors in disordered breathing and cardiorenal dysfunction in chronic heart failure
por: Marcus, Noah J., et al.
Publicado: (2014)

Cardiorenal Systems Modeling: Left Ventricular Hypertrophy and Differential Effects of Antihypertensive Therapies on Hypertrophy Regression
por: Hallow, K. Melissa, et al.
Publicado: (2021)

The Physiopathology of Cardiorenal Syndrome: A Review of the Potential Contributions of Inflammation
por: Kingma, John G., et al.
Publicado: (2017)

Klotho downregulation contributes to myocardial damage of cardiorenal syndrome in sepsis
por: Yan, Fei, et al.
Publicado: (2020)

Cardiorenal Syndromes and Sepsis
por: Chelazzi, C., et al.
Publicado: (2011)

Biomarkers in Cardiorenal Syndromes
por: Fu, Shihui, et al.
Publicado: (2018)

Biomarkers in Cardiorenal Syndrome
por: Goffredo, Giovanni, et al.
Publicado: (2021)

Effect of COVID-19 on cardiorenal axis: known or unknown universe?
por: Armentano, G.M., et al.
Publicado: (2022)

Uremic myopathy: is oxidative stress implicated in muscle dysfunction in uremia?
por: Kaltsatou, Antonia, et al.
Publicado: (2015)

Derivation and elimination of uremic toxins from kidney-gut axis
por: Xu, Ying, et al.
Publicado: (2023)

Editorial: The contributions of women to respiratory physiology and pathophysiology
por: Wang, Kimberley C. W., et al.
Publicado: (2023)

The other side of cardiac Ca(2+) signaling: transcriptional control
por: Domínguez-Rodríguez, Alejandro, et al.
Publicado: (2012)

The Cardiorenal Syndrome: Making the Connection
por: Viswanathan, Gautham, et al.
Publicado: (2010)

The Cardiorenal Syndrome: A Review
por: Shah, B. N., et al.
Publicado: (2010)

Pharmacological Management of Cardiorenal Syndromes
por: House, Andrew A., et al.
Publicado: (2011)

Effects of Statins on Cardiorenal Syndrome
por: Yagi, Shusuke, et al.
Publicado: (2012)

Cardiorenal Syndromes: Pathophysiology to Prevention
por: McCullough, Peter A.
Publicado: (2010)

Cardiorenal syndrome in thalassemia patients
por: Makmettakul, Sorasak, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vaf3i8pquvq5gsiskc7q25di37